STORIA NATURALE E STADIAZIONE DELLE METASTASI CEREBRALI

Translated title of the contribution: Natural history and staging of brain metastases

F. Boccardo, G. Comelli, R. de Menech, G. Mina, S. Zanardi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Intracranial metastases represent 7-17% of all brain tumours, their incidence at autopsy varying between 5.8 and 22% in different series. The neoplasms most commonly metastasizing to the brain are those of lung, breast, renal and skin (melanoma) origin. In two-thirds of cases, intracranial metastases are located within the brain parenchyma, while the remaining third involves the pachymeningeal envelopes. Leptomeningeal metastases are rare and develop mainly from leukemia, lymphomas and breast carcinoma. The route of spread to the central nervous system is usually hematogenous but occasionally direct involvement from adjacent bone or pachymeningeal metastases can occur. Median survival from clinical presentation usually does not exceed a few months. However, brain metastases are the cause of death only in about 15% of patients. This is probably because they occur late in the course of the natural history of the disease, when metastatic deposits in other viable organs have already developed. Due to this, systematic assessment of metastases to the brain is not advisable in all patients but it should be restricted to symptomatic patients and to asymptomatic patients affected by small cell carcinoma and adenocarcinoma of the lung, who could benefit from prophylactic brain irradiation. In symptomatic patients, plain skull X-ray, electroencephalography and computed tomography represent appropriate diagnostic tools to provide accurate information about number, size, site and morphological characteristics of brain metastases.

Original languageItalian
Pages (from-to)1369-1378
Number of pages10
JournalMinerva Medica
Volume75
Issue number22-23
Publication statusPublished - 1984

Fingerprint

Natural History
Neoplasm Metastasis
Brain
Small Cell Carcinoma
X Ray Computed Tomography
Skull
Brain Neoplasms
Cause of Death
Electroencephalography
Autopsy
Melanoma
Lymphoma
Leukemia
Breast
Central Nervous System
Breast Neoplasms
Kidney
Bone and Bones
Lung
Skin

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Boccardo, F., Comelli, G., de Menech, R., Mina, G., & Zanardi, S. (1984). STORIA NATURALE E STADIAZIONE DELLE METASTASI CEREBRALI. Minerva Medica, 75(22-23), 1369-1378.

STORIA NATURALE E STADIAZIONE DELLE METASTASI CEREBRALI. / Boccardo, F.; Comelli, G.; de Menech, R.; Mina, G.; Zanardi, S.

In: Minerva Medica, Vol. 75, No. 22-23, 1984, p. 1369-1378.

Research output: Contribution to journalArticle

Boccardo, F, Comelli, G, de Menech, R, Mina, G & Zanardi, S 1984, 'STORIA NATURALE E STADIAZIONE DELLE METASTASI CEREBRALI', Minerva Medica, vol. 75, no. 22-23, pp. 1369-1378.
Boccardo F, Comelli G, de Menech R, Mina G, Zanardi S. STORIA NATURALE E STADIAZIONE DELLE METASTASI CEREBRALI. Minerva Medica. 1984;75(22-23):1369-1378.
Boccardo, F. ; Comelli, G. ; de Menech, R. ; Mina, G. ; Zanardi, S. / STORIA NATURALE E STADIAZIONE DELLE METASTASI CEREBRALI. In: Minerva Medica. 1984 ; Vol. 75, No. 22-23. pp. 1369-1378.
@article{3a48173903b34c36b79f6492692f4181,
title = "STORIA NATURALE E STADIAZIONE DELLE METASTASI CEREBRALI",
abstract = "Intracranial metastases represent 7-17{\%} of all brain tumours, their incidence at autopsy varying between 5.8 and 22{\%} in different series. The neoplasms most commonly metastasizing to the brain are those of lung, breast, renal and skin (melanoma) origin. In two-thirds of cases, intracranial metastases are located within the brain parenchyma, while the remaining third involves the pachymeningeal envelopes. Leptomeningeal metastases are rare and develop mainly from leukemia, lymphomas and breast carcinoma. The route of spread to the central nervous system is usually hematogenous but occasionally direct involvement from adjacent bone or pachymeningeal metastases can occur. Median survival from clinical presentation usually does not exceed a few months. However, brain metastases are the cause of death only in about 15{\%} of patients. This is probably because they occur late in the course of the natural history of the disease, when metastatic deposits in other viable organs have already developed. Due to this, systematic assessment of metastases to the brain is not advisable in all patients but it should be restricted to symptomatic patients and to asymptomatic patients affected by small cell carcinoma and adenocarcinoma of the lung, who could benefit from prophylactic brain irradiation. In symptomatic patients, plain skull X-ray, electroencephalography and computed tomography represent appropriate diagnostic tools to provide accurate information about number, size, site and morphological characteristics of brain metastases.",
author = "F. Boccardo and G. Comelli and {de Menech}, R. and G. Mina and S. Zanardi",
year = "1984",
language = "Italian",
volume = "75",
pages = "1369--1378",
journal = "Minerva Medicolegale e Archivio di Antropologia Criminale",
issn = "0026-4806",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "22-23",

}

TY - JOUR

T1 - STORIA NATURALE E STADIAZIONE DELLE METASTASI CEREBRALI

AU - Boccardo, F.

AU - Comelli, G.

AU - de Menech, R.

AU - Mina, G.

AU - Zanardi, S.

PY - 1984

Y1 - 1984

N2 - Intracranial metastases represent 7-17% of all brain tumours, their incidence at autopsy varying between 5.8 and 22% in different series. The neoplasms most commonly metastasizing to the brain are those of lung, breast, renal and skin (melanoma) origin. In two-thirds of cases, intracranial metastases are located within the brain parenchyma, while the remaining third involves the pachymeningeal envelopes. Leptomeningeal metastases are rare and develop mainly from leukemia, lymphomas and breast carcinoma. The route of spread to the central nervous system is usually hematogenous but occasionally direct involvement from adjacent bone or pachymeningeal metastases can occur. Median survival from clinical presentation usually does not exceed a few months. However, brain metastases are the cause of death only in about 15% of patients. This is probably because they occur late in the course of the natural history of the disease, when metastatic deposits in other viable organs have already developed. Due to this, systematic assessment of metastases to the brain is not advisable in all patients but it should be restricted to symptomatic patients and to asymptomatic patients affected by small cell carcinoma and adenocarcinoma of the lung, who could benefit from prophylactic brain irradiation. In symptomatic patients, plain skull X-ray, electroencephalography and computed tomography represent appropriate diagnostic tools to provide accurate information about number, size, site and morphological characteristics of brain metastases.

AB - Intracranial metastases represent 7-17% of all brain tumours, their incidence at autopsy varying between 5.8 and 22% in different series. The neoplasms most commonly metastasizing to the brain are those of lung, breast, renal and skin (melanoma) origin. In two-thirds of cases, intracranial metastases are located within the brain parenchyma, while the remaining third involves the pachymeningeal envelopes. Leptomeningeal metastases are rare and develop mainly from leukemia, lymphomas and breast carcinoma. The route of spread to the central nervous system is usually hematogenous but occasionally direct involvement from adjacent bone or pachymeningeal metastases can occur. Median survival from clinical presentation usually does not exceed a few months. However, brain metastases are the cause of death only in about 15% of patients. This is probably because they occur late in the course of the natural history of the disease, when metastatic deposits in other viable organs have already developed. Due to this, systematic assessment of metastases to the brain is not advisable in all patients but it should be restricted to symptomatic patients and to asymptomatic patients affected by small cell carcinoma and adenocarcinoma of the lung, who could benefit from prophylactic brain irradiation. In symptomatic patients, plain skull X-ray, electroencephalography and computed tomography represent appropriate diagnostic tools to provide accurate information about number, size, site and morphological characteristics of brain metastases.

UR - http://www.scopus.com/inward/record.url?scp=0021258664&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021258664&partnerID=8YFLogxK

M3 - Articolo

VL - 75

SP - 1369

EP - 1378

JO - Minerva Medicolegale e Archivio di Antropologia Criminale

JF - Minerva Medicolegale e Archivio di Antropologia Criminale

SN - 0026-4806

IS - 22-23

ER -